Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanosilver Fluoride vs Low-Level Laser Therapy for MIH Hypersensitivity
NCT06348849Phase 3Completed
- Sponsor
- Alexandria University
- Start
- Apr 2024
- Primary completion
- Jun 2024
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nanosilver fluoride in dentin hypersensitivity (DH), sponsored by Alexandria University. Started Apr 2024; status: completed.
02
Drugs
nanosilver fluoride
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT06348849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06348849.